Back to Search
Start Over
Optimizing the corticosteroid dose in steroid-sensitive nephrotic syndrome
- Source :
- Pediatric Nephrology. January, 2022, Vol. 37 Issue 1, p37, 11 p.
- Publication Year :
- 2022
-
Abstract
- The use of corticosteroids in the treatment of steroid-sensitive nephrotic (SSNS) syndrome in children has evolved surprisingly slowly since the ISKDC consensus over 50 years ago. From a move towards longer courses of corticosteroid to treat the first episode in the 1990s and 2000s, more recent large, well-designed randomized controlled trials (RCTs) have unequivocally shown no benefit from an extended course, although doubt remains whether this applies across all age groups. With regard to prevention of relapses, daily ultra-low-dose prednisolone has recently been shown to be more effective than low-dose alternate-day prednisolone. Daily low-dose prednisolone for a week at the time of acute viral infection seems to be effective in the prevention of relapses but the results of a larger RCT are awaited. Recently, corticosteroid dosing to treat relapses has been questioned, with data suggesting lower doses may be as effective. The need for large RCTs to address the question of whether corticosteroid doses can be reduced was the conclusion of the authors of the recent corticosteroid therapy for nephrotic syndrome in children Cochrane update. This review summarizes development in thinking on corticosteroid use in SSNS and makes suggestions for areas that merit further scrutiny.<br />Author(s): Martin T. Christian [sup.1] , Andrew P. Maxted [sup.1] Author Affiliations: (1) Department of Paediatric Nephrology, Nottingham Children's Hospital, , NG7 2UH, Nottingham, UK Introduction [Displayed Quote]What's in a [...]
Details
- Language :
- English
- ISSN :
- 0931041X
- Volume :
- 37
- Issue :
- 1
- Database :
- Gale General OneFile
- Journal :
- Pediatric Nephrology
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.687022802
- Full Text :
- https://doi.org/10.1007/s00467-021-04985-1